James Hughes, dean of the Bloustein School of Planning & Public Policy at Rutgers University, also said he did not see much duplication to be cut.
“Allergan has a sales staff that deals with their specific products, and Pfizer has its staff for different products. So I would think that staff is going to stay intact,” Hughes said. “It shouldn’t have much of an impact one way or the other on New Jersey.”
Wall Street Journal, November 23
Posttraumatic Stress Disorder and Trauma-Informed Care Introduction Prison and jail populations have dense and patterned concentrations of childhood and adult trauma (Wolff, 2022). The maturing effects of childhood trauma have been extensively studied for decades,...
Alumnus Helps Rethink Jersey City's Public Spaces: A Conversation with Barkha Patel MCRP '15 Dean Stuart Shapiro talks to alumnus Barkha Patel, MCRP '15 this week on EJB Talks. Initially a sociology undergraduate at Rutgers, Barkha discusses how a chance visit by Dean...
Report Release: Equity Initiatives in the United States Read Report The New Jersey State government proactively advances equity through its Office of Equity in the Office of the Governor, and through budget initiatives such as the “Cover all Kids” program ensuring...
Adrian Ponichtera (MCRP '26) is the recipient of the New Jersey County Planners Association's George Ververides Honorary Scholarship. The scholarship is open to New Jersey residents entering their third or fourth year of undergraduate study or advanced degrees at a...
Soumitra Bhuyan, Executive Director of Health Administration Programs and Associate Professor at Rutgers University-New Brunswick’s Edward J. Bloustein School of Planning and Public Policy, is the co-editor of a new textbook Fundamentals of Healthcare...